estradiol 0.05 MG per 24 HR Vaginal System, 90 Day
- RxCUI
- 848331
- RxNorm name
- estradiol 0.05 MG per 24 HR Vaginal System, 90 Day
- Display name
- estradiol 0.05 MG per 24 HR Vaginal System, 90 Day
- Full name
- estradiol 0.05 MG per 24 HR Vaginal System, 90 Day
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Femring | ESTRADIOL ACETATE | Millicent US, Inc. | 7aaa97f9-a9d1-c815-e053-2991aa0afb9e | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 848331 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7aaa97f9-a9d1-c815-e053-2991aa0afb9e | estradiol acetate 0.05 MG per 24HR 3 Month Vaginal System [PSN] · 90 DAY estradiol 0.00208 MG/HR Vaginal System [SCD] · estradiol 0.05 MG per 24 HR Vaginal System, 90 Day [SY] | 3 | 7 | These highlights do not include all the information needed to use FEMRING safely and effectively. See Full Prescribing Information for FEMRING. Femring ® (estradiol acetate vaginal ring) Initial U.S. Approval: 1975 | 20251209 |